Telemedicine Technologies is an engineering company specialising in eHealth information systems, a fast-growing sector with many opportunities.
Telemedicine Technologies’ activity is a mix of various disciplines (Software engineering, space technologies, big data and data science, medicine and clinical operations …) in an international environment and a start-up spirit.
Telemedicine Technologies develops and provides solutions that contribute to improving the care system, patient monitoring and clinical aspects in a wide variety of uses.
Join us
You will be part of our software development team or will work on projects for our health sectors clients: pharmaceutical companies, Biotechs, Medtechs, CROs, public hospitals, patient associations…
You could also work on collaborative R&D projects or international programmes
Internship or young graduate, your aim is to obtain new skills, to fully understand the business, the solutions, and Telemedicine Technologies methods. You will also be responsible for: writing software development specifications, developing, testing, validating, configuration and training.
You will be trained in the methodologies, working environment (Hibernate, VAADIN) standards (CDISC), and the quality assurance processes of Telemedicine Technologies Quickly gaining experience, you will use your knowledge and experience to carry out development tasks or increasingly complex project activities.
As a manager you will lead a development team, or you will be in charge of a project to deliver a solution and services that meet all expectations.
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
April 29, 2025
May 5 & 6 – Basel Telemedicine Technologies is pleased to present its CleanWeb™ eClinical suite, offering flexible, regulatory-compliant solutions tailored to every phase of clinical trials. Our platform includes a wide range of modules, such as eCRF, Randomization & Trial Supply Management, ePRO, eTMF, eConsent, Data Visualization, Vigilance, Imaging, CTMS, and more. We invite […]
April 29, 2025
Fierce Biotech The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as reported in Deloitte’s annual report, “Measuring the return from pharmaceutical innovation.” In 2024, the average […]
April 29, 2025
Biopharm International In January 2025, Samsung Biologics signed a six-year, $1.4 billion contract manufacturing agreement with an as-yet undisclosed European pharmaceutical company, with production to take place at Samsung’s manufacturing site in Songdo, South Korea (1). Simultaneously, at the J.P. Morgan Healthcare Conference held in San Francisco, the company announced plans to complete construction of […]